Clinical Trial Update: Long-term Safety Study of Alogliptin Used in Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan [Phase 2, Phase 3]

View source ↗

Summary

This update summarizes the completed long-term safety study of alogliptin in combination with a thiazolidinedione in Japanese participants with Type 2 Diabetes.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Actos (Pioglitazone)
• Nesina (alogliptin)

Snippet

Sponsor: Takeda | Conditions: Type 2 Diabetes Mellitus | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2011-09-02